• Phase


  • Contact person

    Mats Hansen, CEO

  • Email


  • Area


Spago Imaging

Spago Nanomedical develops nanomedical products for cancer diagnostics and treatment. The company’s main activities are focused on developing SpagoPix, a nanomedical contrast agent for MRI, and the therapeutic development project Tumorad, for tumor selective radionuclide treatment.

Mats Hansen holds a Ph.D. in plant biochemistry and a Master in biology. He has extensive experience in project management, clinical development and business development within oncology pharmaceuticals. His prior roles include director of Project Management and Head of Knowledge Management at Active Biotech AB, where he previously also has held various positions within information management, IP and business development. Mats is also Member of the board of Ekoscandica Naturguide AB.

© 2023 Copyright SmiLe Incubator